Compounds > 1-nitrohydroxyphenyl-n-benzoylalanine
Page last updated: 2024-09-05

1-nitrohydroxyphenyl-n-benzoylalanine and transforming growth factor beta

1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with transforming growth factor beta in 2 studies

Compound Research Comparison

Studies
(1-nitrohydroxyphenyl-n-benzoylalanine)		Trials
(1-nitrohydroxyphenyl-n-benzoylalanine)		Recent Studies (post-2010)
(1-nitrohydroxyphenyl-n-benzoylalanine)		Studies
(transforming growth factor beta)		Trials
(transforming growth factor beta)		Recent Studies (post-2010) (transforming growth factor beta)
4203649,11956017,610

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Afify, EA; Darwish, IE; El-Ganainy, SO; El-Mezayen, NS; Noah, AA1
Li, S; Xue, J1

Other Studies

2 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and transforming growth factor beta

ArticleYear
Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl
    European journal of pharmacology, 2023, Nov-15, Volume: 959

    Topics: Animals; Endothelial Cells; Fibrosis; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis; Neuropilin-1; Rats; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2023
Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis.
    Cellular and molecular biology (Noisy-le-Grand, France), 2023, Nov-15, Volume: 69, Issue:11

    Topics: Animals; Cell Proliferation; Fibroblasts; Galectin 1; Lung; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Transforming Growth Factor beta

2023